Mary Beth G Erstad

Title: The Innovative Contributions of Mary Beth G Erstad

Introduction

Mary Beth G Erstad is a notable inventor based in Plymouth, MN (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for bleeding disorders. Her innovative approach has led to the creation of a unique oral solution that addresses critical medical needs.

Latest Patents

Mary Beth G Erstad holds 1 patent for her invention titled "Tranexamic acid oral solution." This patent outlines methods and compositions designed to treat patients with bleeding disorders during or after dental procedures. The solution aims to reduce bleeding and the need for factor replacement therapy. The aqueous pharmaceutical compositions she developed include tranexamic acid, sodium carboxymethyl cellulose, Tween® 20, and menthol. These compositions exhibit good long-term stability, minimal discoloration over time, and reduced bitterness compared to traditional solutions.

Career Highlights

Throughout her career, Mary Beth has demonstrated a commitment to advancing medical treatments. Her work has not only contributed to the scientific community but has also provided practical solutions for patients facing challenging health issues. Her innovative spirit and dedication to research have positioned her as a valuable asset in her field.

Collaborations

Mary Beth has collaborated with esteemed colleagues, including Thomas Gerner Jacobsen and Mohammad Alkhalili. These partnerships have fostered an environment of creativity and innovation, leading to the development of effective medical solutions.

Conclusion

Mary Beth G Erstad's contributions to the field of pharmaceuticals exemplify the impact of innovation in healthcare. Her work on tranexamic acid oral solutions showcases her dedication to improving patient outcomes. Through her inventions, she continues to inspire future advancements in medical treatments.